BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 8395170)

  • 1. Myocardial fibrosis: role of angiotensin II and aldosterone.
    Weber KT; Brilla CG; Campbell SE; Guarda E; Zhou G; Sriram K
    Basic Res Cardiol; 1993; 88 Suppl 1():107-24. PubMed ID: 8395170
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Myocardial fibrosis and the concepts of cardioprotection and cardioreparation.
    Weber KT; Brilla CG; Campbell SE; Reddy HK
    J Hypertens Suppl; 1992 Jul; 10(5):S87-94. PubMed ID: 1403238
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fibrosis of atria and great vessels in response to angiotensin II or aldosterone infusion.
    Sun Y; Ramires FJ; Weber KT
    Cardiovasc Res; 1997 Jul; 35(1):138-47. PubMed ID: 9302358
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regulation and role of myocardial collagen matrix remodeling in hypertensive heart disease.
    Funck RC; Wilke A; Rupp H; Brilla CG
    Adv Exp Med Biol; 1997; 432():35-44. PubMed ID: 9433509
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Spironolactone: renaissance of anti-aldosterone therapy in heart failure?].
    Brilla CG; Schencking M; Scheer C; Rupp H
    Praxis (Bern 1994); 1997 Apr; 86(14):566-74. PubMed ID: 9198851
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Factors associated with reactive and reparative fibrosis of the myocardium.
    Weber KT; Brilla CG
    Basic Res Cardiol; 1992; 87 Suppl 1():291-301. PubMed ID: 1497573
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mineralocorticoid excess, dietary sodium, and myocardial fibrosis.
    Brilla CG; Weber KT
    J Lab Clin Med; 1992 Dec; 120(6):893-901. PubMed ID: 1453111
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chronic mineralocorticoid excess and cardiovascular remodeling.
    Weber KT; Sun Y; Campbell SE; Slight SH; Ganjam VK; Griffing GT; Swinfard RW; Diaz-Arias AA
    Steroids; 1995 Jan; 60(1):125-32. PubMed ID: 7792797
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Temporal differences in fibroblast proliferation and phenotype expression in response to chronic administration of angiotensin II or aldosterone.
    Campbell SE; Janicki JS; Weber KT
    J Mol Cell Cardiol; 1995 Aug; 27(8):1545-60. PubMed ID: 8523418
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pathologic hypertrophy with fibrosis: the structural basis for myocardial failure.
    Weber KT; Brilla CG; Campbell SE; Zhou G; Matsubara L; Guarda E
    Blood Press; 1992 Aug; 1(2):75-85. PubMed ID: 1366263
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bradykinin receptor and tissue ACE binding in myocardial fibrosis: response to chronic angiotensin II or aldosterone administration in rats.
    Sun Y; Ratajska A; Weber KT
    J Mol Cell Cardiol; 1995 Feb; 27(2):813-22. PubMed ID: 7776388
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Myocardial fibrosis: role of ventricular systolic pressure, arterial hypertension, and circulating hormones.
    Weber KT; Brilla CG; Janicki JS; Reddy HK; Campbell SE
    Basic Res Cardiol; 1991; 86 Suppl 3():25-31. PubMed ID: 1781767
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Collagen metabolism in cultured adult rat cardiac fibroblasts: response to angiotensin II and aldosterone.
    Brilla CG; Zhou G; Matsubara L; Weber KT
    J Mol Cell Cardiol; 1994 Jul; 26(7):809-20. PubMed ID: 7966349
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Angiotensin-converting enzyme and myocardial fibrosis in the rat receiving angiotensin II or aldosterone.
    Sun Y; Ratajska A; Zhou G; Weber KT
    J Lab Clin Med; 1993 Oct; 122(4):395-403. PubMed ID: 8228553
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aldosterone mediates angiotensin II-induced interstitial cardiac fibrosis via a Nox2-containing NADPH oxidase.
    Johar S; Cave AC; Narayanapanicker A; Grieve DJ; Shah AM
    FASEB J; 2006 Jul; 20(9):1546-8. PubMed ID: 16720735
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Myocardial fibrosis associated with aldosterone or angiotensin II administration: attenuation by calcium channel blockade.
    Ramires FJ; Sun Y; Weber KT
    J Mol Cell Cardiol; 1998 Mar; 30(3):475-83. PubMed ID: 9515025
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Myocardial fibrosis and the renin-angiotensin-aldosterone system.
    Weber KT; Brilla CG
    J Cardiovasc Pharmacol; 1992; 20 Suppl 1():S48-54. PubMed ID: 1380619
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Angiotensin II and aldosterone receptor binding in rat heart and kidney: response to chronic angiotensin II or aldosterone administration.
    Sun Y; Weber KT
    J Lab Clin Med; 1993 Oct; 122(4):404-11. PubMed ID: 8228554
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacological modulation of cardiac fibroblast function.
    Brilla CG; Maisch B; Rupp H; Funck R; Zhou G; Weber KT
    Herz; 1995 Apr; 20(2):127-34. PubMed ID: 7774864
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structural remodelling of the heart by fibrous tissue: role of circulating hormones and locally produced peptides.
    Weber KT; Sun Y; Campbell SE
    Eur Heart J; 1995 Dec; 16 Suppl N():12-8. PubMed ID: 8682056
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.